In Anti-Gene-Patenting Case, Myriad Files for Summary Judgment; USPTO Requests Court to Dismiss Charges

Myriad would like the court to decide the ACLU's anti-gene-patenting suit ahead of the case going to trial, while the USPTO would like to the court to dismiss the claims against it.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.